Latest Stock Split Details
Key information about ProShares - Ultra Nasdaq Biotechnology's most recent stock split
Split Date: 2015-05-20
Split Ratio: 2:1
Price Before Split: N/A
Price After Split: N/A
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 2.00 times more shares (a 2:1 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of ProShares - Ultra Nasdaq Biotechnology's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2015-05-20 | 2:1 | No | N/A | N/A |
| 2014-01-24 | 2:1 | No | N/A | N/A |
| 2012-10-05 | 2:1 | No | N/A | N/A |
About ProShares - Ultra Nasdaq Biotechnology
Company overview and industry information
ProShares - Ultra Nasdaq Biotechnology (BIB) operates in the Asset Management - Leveraged industry. The recent 2-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Asset Management - Leveraged
Go to ProShares - Ultra Nasdaq Biotechnology Summary